This is the web version of CEO Daily. To get it delivered to your inbox, sign up here.
The big news yesterday—and possibly the best news since the pandemic began—is that Moderna Therapeutics announced positive Phase I test results from its COVID 19 vaccine candidate. It’s a small test—just 8 people—but all developed antibodies from the vaccine, suggesting a path to success by early next year.
Last week, I interviewed the man who gave birth to Moderna—Noubar Afeyan of Flagship Pioneering—for our podcast, Leadership Next, out this morning here. It was one of the most interesting conversations I’ve
Read more Source: fortune.com